title: A pilot study of busulfan, cyclophosphamide and etoposide followed by autologous transplantation for acute myeloid leukemia in remission.
authors.affiliation: Bone Marrow Transplant Program, University of Connecticut Health Center, Farmington, Conn 06030, USA.
authors.forename: S
authors.initials: S
authors.lastname: Bilgrami
authors.forename: R L
authors.initials: RL
authors.lastname: Edwards
authors.forename: R D
authors.initials: RD
authors.lastname: Bona
authors.forename: D
authors.initials: D
authors.lastname: Kazierad
authors.forename: F
authors.initials: F
authors.lastname: Furlong
authors.forename: J
authors.initials: J
authors.lastname: Fox
authors.forename: J
authors.initials: J
authors.lastname: Clive
authors.forename: B H
authors.initials: BH
authors.lastname: Naqvi
authors.forename: P J
authors.initials: PJ
authors.lastname: Tutschka
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012008:Recurrence; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D005047:Etoposide; D003520:Cyclophosphamide; D002066:Busulfan